Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Sep 13, 2023Professional navigation requires a set of skills and competencies to ensure patients receive recommended care that can improve outcomesWASHINGTON D.C. – September 13, 2023 – Earlier today, President Joe Biden and First Lady Jill Biden issued a Fact Sheet to announce new actions and commitments to end cancer as we know it. We...
Sep 11, 2023Researchers from the American Cancer Society stress the need to invest in clinician training and community outreach to improve colorectal cancer screening ratesATLANTA, September 11, 2023 — In a new study led by researchers at the American Cancer Society (ACS), most adults (73.2 %) in the United States overdue for colorectal cancer screening (CRC)...
Sep 6, 2023Researchers from the American Cancer Society stress the need to update oncology infrastructure in the country to better treat patientsThe study showed that 55% of CRC patients in SSA survived two years after a diagnosis of their disease, compared to 84% of patients in the United States, and the risk of dying from CRC was 67% higher in patients diagnosed in low-income countries than those diagnosed in middle-income countries.
Aug 30, 2023The American Cancer Society’s Dr. Lorelei Mucci stresses the need for early detection, screening, and prevention strategies, especially among at-risk communities.Prostate cancer is the second leading cause of cancer death among men in the United States. According to the latest research from scientists at the American Cancer Society (ACS), more than 288,000 men will be diagnosed with the disease this year, with close to 35,000 deaths. Black men are two times more likely to die from the disease than White men and have the highest death rate for prostate cancer of any racial and ethnic group. However, when prostate cancer is detected early, the odds of survival are high.
Aug 16, 2023American Cancer Society’s Impact Venture Fund Announces Annual Results and New Framework that Measures Investments’ Impact on Mission to End CancerBrightEdge LLC, the American Cancer Society’s (ACS) venture capital and impact investment arm, published its most recent annual report, featuring how its portfolio of 18 companies has the potential to improve the lives of more than 1.5 million cancer patients and their families.